Abivax Sa (ABVX) Annual Balance Sheets

Annual · GAAP · USD millions
Access ABVX quarterly Balance Sheets →
Balance sheet performance over multiple periods helps investors evaluate the financial resilience of Abivax Sa.
Annual Report, GAAP in USD millions
ITEM
(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023)
Assets
Cash And Cash Equivalents606.38
Cash & Short-term Investments606.00
Other Current Assets38.71
Total Current Assets646.94
Goodwill net21.62
Intangible Assets7.75
Tax Assets, Noncurrent283.89
Other Assets, Noncurrent16.44
Other Noncurrent Nonfinancial Assets-
Noncurrent Assets-
Other Current Financial Assets-
Current Receivables And Current Prepaid Expenses-
Other Noncurrent Nonfinancial Assets-
Other Noncurrent Nonfinancial Assets0.70
Noncurrent Assets37.07
Other Current Financial Assets23.98
Current Receivables And Current Prepaid Expenses14.72
Total Assets685.78
Liabilities
Accounts Payable44.07
Other Liabilities, Current70.58
Total Current Liabilities73.96
Total Long-term Debt0.00
Accrued Income Taxes, Noncurrent20.67
Total Liabilities151.55
Stockholders' Equity
Other Equity509.83
Common Stockholder's Equity509.83
Total Stockholder's Equity534.23
Liabilities & Stockholder's Equity685.78
4 historic quarters locked

Sign in to unlock the full Abivax Sa balance sheet history.

About Abivax S A Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 20-F filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001956827-26-000012

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License